|
|
||||||||
Papers In Press, published online ahead of print March 16, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Division of Biopharmaceutics, LACDR, Gorlaeus Laboratories, Leiden 2333CC
Corresponding Author: r.out{at}lacdr.leidenuniv.nl
The function of scavenger receptor class B type I (SR-BI) in mediating the selective uptake of HDL cholesterol esters is well established. In SR-BI deficient mice we recently observed a delayed postprandial triglyceride response (Out et al., J.Biol.Chem, 279 (2004)18401-18406) suggesting an additional role for SR-BI in facilitating chylomicron metabolism. In the present investigation, we assessed the effect of adenovirus-mediated hepatic overexpression of SR-BI (Ad.SR-BI) in C57BL/6J mice on serum lipids and chylomicron metabolism. Infection of 5x108 pfu per mouse of Ad.SR-BI significantly decreases serum cholesterol (>90%), phospholipids (>90%), and triglyceride levels (50%), accompanied by a 41.4% reduction (p<0.01) in apoB100 levels. The relevance of SR-BI overexpression for in vivo chylomicron (remnant) metabolism was evaluated by studying the effect on an intra-gastric fat load-induced postprandial triglyceride response. The postprandial triglyceride response is 2-fold lower in mice treated with Ad.SR-BI compared to control mice (area-under-the curve 31.4 ± 2.4 versus 17.7 ± 3.2; P<0.05). Hepatic expression levels of genes known to be involved in serum cholesterol and triglyceride clearance were tested by real-time PCR and it appears that the mRNA expression levels of the LDLr, LRP1, ABCA1, HMG-CoA reductase, ABCG1, ABCG5, ABCG8, CYP7A1, CYP27, BSEP, hepatic lipase, and lipoprotein lipase are unchanged and thus could not account for the decreased plasma triglyceride levels and the change in postprandial response. We conclude that overexpression of SR-BI accelerates chylomicron metabolism possibly by mediating the initial capture of chylomicron remnants by the liver whereby the subsequent internalization can be exerted by additional receptor systems like the LDL receptor and LRP1.
Revised on February 23, 2005
Accepted on March 8, 2005
Adenovirus-mediated hepatic overexpression of scavenger receptor BI accelerates chylomicron metabolism in C57BL/6J mice
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. A. Fenske, A. Yesilaltay, R. Pal, K. Daniels, A. Rigotti, M. Krieger, and O. Kocher Overexpression of the PDZ1 Domain of PDZK1 Blocks the Activity of Hepatic Scavenger Receptor, Class B, Type I by Altering Its Abundance and Cellular Localization J. Biol. Chem., August 8, 2008; 283(32): 22097 - 22104. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hu, C. C. van der Hoogt, S. M. S. Espirito Santo, R. Out, K. E. Kypreos, B. J. M. van Vlijmen, T. J. C. Van Berkel, J. A. Romijn, L. M. Havekes, K. W. van Dijk, et al. The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI J. Lipid Res., July 1, 2008; 49(7): 1553 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Densupsoontorn, Y. A. Carpentier, R. Racine, F. M. Murray, T. Seo, R. Ramakrishnan, and R. J. Deckelbaum CD36 and Proteoglycan-Mediated Pathways for (n-3) Fatty Acid Enriched Triglyceride-Rich Particle Blood Clearance in Mouse Models In Vivo and in Peritoneal Macrophages In Vitro J. Nutr., February 1, 2008; 138(2): 257 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Out, W. Jessup, W. Le Goff, M. Hoekstra, I. C. Gelissen, Y. Zhao, L. Kritharides, G. Chimini, J. Kuiper, M. J. Chapman, et al. Coexistence of Foam Cells and Hypocholesterolemia in Mice Lacking the ABC Transporters A1 and G1 Circ. Res., January 4, 2008; 102(1): 113 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. van der Hoogt, W. de Haan, M. Westerterp, M. Hoekstra, G. M. Dallinga-Thie, J. A. Romijn, H. M. G. Princen, J. W. Jukema, L. M. Havekes, and P. C. N. Rensen Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression J. Lipid Res., August 1, 2007; 48(8): 1763 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. F. Nieland, J. T. Shaw, F. A. Jaipuri, Z. Maliga, J. L. Duffner, A. N. Koehler, and M. Krieger Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI J. Lipid Res., August 1, 2007; 48(8): 1832 - 1845. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, J. Delgado-Lista, J. Lopez-Miranda, F. Perez-Jimenez, C. Marin, P. Perez-Martinez, P. Gomez, and J. M. Ordovas Scavenger Receptor Class B Type I (SCARB1) c.1119C>T Polymorphism Affects Postprandial Triglyceride Metabolism in Men J. Nutr., March 1, 2007; 137(3): 578 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu, W. Zhang, P. G. Yancey, M. J. Koury, Y. Zhang, S. Fazio, and M. F. Linton Macrophage Apolipoprotein E Reduces Atherosclerosis and Prevents Premature Death in Apolipoprotein E and Scavenger Receptor-Class BI Double-Knockout Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 150 - 156. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |